4461 - 4470 of 8808 Results
Title
Year
- Error in Figure2021OPENTitle: Error in FigureJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 327Issue #: 1Start Page: 86End Page: 86Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jama.2021.16187Best OA location URL: https://jamanetwork.com/journals/jama/articlepdf/2787448/jama_2021_cx_210045_1640892482.39958.pdfCitation Count: 0
-
OPENTitle: How Prolonged Isolation Affects People With Parkinson Disease During the COVID-19 PandemicJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 327Issue #: 9Start Page: 801End Page: 801Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jama.2022.1510Best OA location URL: https://jamanetwork.com/journals/jama/articlepdf/2789055/jama_suran_2022_mn_220006_1645750114.50702.pdfCitation Count: 6
-
OPENTitle: Association of Plasma and Cerebrospinal Fluid Alzheimer Disease Biomarkers With Race and the Role of Genetic Ancestry, Vascular Comorbidities, and Neighborhood FactorsJournal Name: JAMA Network OpenPublisher: American Medical Association (AMA)Vol: 5Issue #: 10Start Page: e2235068End Page: e2235068Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1001/jamanetworkopen.2022.35068Best OA location URL: https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2797044/hajjar_2022_oi_220997_1664303851.08078.pdfCitation Count: 50
-
RESTRICTEDTitle: Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1H-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson’s DiseaseJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 65Issue #: 24Start Page: 16801End Page: 16817Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.jmedchem.2c01605Citation Count: 17
-
RESTRICTEDTitle: Monitoring gait at home with radio waves in Parkinson’s disease: A marker of severity, progression, and medication responseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 14Issue #: 663Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.adc9669Citation Count: 57
-
RESTRICTEDTitle: Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson’s diseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 14Issue #: 648Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.abj2658Citation Count: 192
-
OPENTitle: Association of a common genetic variant with Parkinson’s disease is mediated by microgliaJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 14Issue #: 655Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.abp8869Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9809150Citation Count: 74
-
OPENTitle: GPNMB confers risk for Parkinson’s disease through interaction with α-synucleinJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 377Issue #: 6608Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/science.abk0637Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9870036Citation Count: 113
-
OPENTitle: Library-Derived Peptide Aggregation Modulators of Parkinson’s Disease Early-Onset α-Synuclein VariantsJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 13Issue #: 12Start Page: 1790End Page: 1804Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.2c00190Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.2c00190Citation Count: 5
-
OPENTitle: A NAC domain mutation (E83Q) unlocks the pathogenicity of human alpha-synuclein and recapitulates its pathological diversityJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 8Issue #: 17Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/sciadv.abn0044Best OA location URL: https://www.science.org/doi/pdf/10.1126/sciadv.abn0044?download=trueCitation Count: 35